跳至主要内容
临床试验/CTRI/2026/07/113673
CTRI/2026/07/113673进行中(未招募)Unknown

An Open Label, Prospective, Single Arm Observation Study on H-Vit Hair Serum of Systopic Laboratories Pvt. Ltd. to in Adults Looking to Improve Hair Health in Real World Clinical Practice - NIL

Systopic Laboratories Private Limited0 个研究点目标入组 300 人开始时间: 2026年7月30日最近更新:

试验速览

阶段
Unknown
状态
进行中(未招募)
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Clinically healthy adult subjects who are routinely being prescribed H-Vit Hair Serum of Systopic Laboratories, between the ages of 21 and 55 years - both ages and all genders inclusive, looking to improve their hair health.
  • Subjects with complaints of non-associated excessive hair fall, brittle or thin hair, dull hair, dry or damaged hair.
  • Subjects who are willing to abstain from the use of any oral or topical medications not limited to collagen, biotin supplements indicated and improving hair fall and other hair health parameters.
  • Subjects who are willing to give informed consent for participation, able to comprehend and understand the responsibilities during screening and treatment period.
  • Subjects who are willing not to participate in any other clinical trial during participation in the current trial.

排除标准

  • Subjects with known hypersensitivity to the ingredients of the investigational product
  • Subjects who have had an active trichological procedure done upto 3 months prior to screening
  • Subjects who have scalp conditions not limited to seborrheic dermatitis, psoriasis, alopecia areata, significant scalp scarring that prevents proper examination or evaluation of study criteria.
  • Subjects with Trichotillomania
  • Subjects who have anaemia or iron deficiency.
  • Subjects who have previously undergone hair transplantation procedures.
  • Subjects who have an active infection, disease or disorder that will prevent them from fully satisfying the responsibilities of the study.
  • Subjects with history of seizures, uncontrolled diabetes, hypertension or major cardiac illness like congestive heart failure etc.
  • Subjects suffering from or on remission from cancer of any type less than 5 years at the time of screening
  • Subjects who are planning a pregnancy and or currently breastfeeding.
  • Subjects who have participated in a clinical study less than 1 month before screening.
  • Any significant medical condition - e.g., significant psychiatric or neurological disorders, active alcohol or drug abuse, etc. - any medical condition that is unstable or poorly controlled or other factor - e.g., planned relocation - that the Investigator felt would interfere with study evaluations and study participation.
  • Subjects who mentally unable to comprehend the responsibilities and adhere to the stipulations of the protocol
  • Subjects, who in the opinion of the Investigator are not eligible for enrolment in the study.

研究者

相似试验